Virginie Bito, Dominique Hansen, Elvire Verbaanderd, Lisa Van Ryckeghem, Paul Dendale, Thibault Petit, Siddharth Jogani, Charly Keytsman, Ines Frederix, Sarah Stroobants, Jan Verwerft, Elise Bakelants, VAN RYCKEGHEM, Lisa, KEYTSMAN, Charly, Verbaanderd, Elvire, FREDERIX, Ines, Bakelants, Elise, Petit, Thibault, Jogani, Siddharth, Stroobants, Sarah, DENDALE, Paul, BITO, Virginie, VERWERFT, Jan, and HANSEN, Dominique
Background and purpose The development of myocardial fibrosis is a major complication of Type 2 diabetes mellitus (T2DM), impairing myocardial deformation and, therefore, cardiac performance. It remains to be established whether abnormalities in longitudinal strain (LS) exaggerate or only occur in well-controlled T2DM, when exposed to exercise and, therefore, cardiac stress. We therefore studied left ventricular LS at rest and during exercise in T2DM patients vs. healthy controls. Methods and results Exercise echocardiography was applied with combined breath-by-breath gas exchange analyses in asymptomatic, well-controlled (HbA1c: 6.9 ± 0.7%) T2DM patients (n = 36) and healthy controls (HC, n = 23). Left ventricu-lar LS was assessed at rest and at peak exercise. Peak oxygen uptake (V̇ O 2peak) and workload (W peak) were similar between groups (p > 0.05). Diastolic (E, e' s , E/e') and systolic function (left ventricular ejection fraction) were similar at rest and during exercise between groups (p > 0.05). LS (absolute values) was significantly lower at rest and during exercise in T2DM vs. HC (17.0 ± 2.9% vs. 19.8 ± 2% and 20.8 ± 4.0% vs. 23.3 ± 3.3%, respectively, p < 0.05). The response in myocardial deformation (the change in LS from rest up to peak exercise) was similar between groups (+ 3.8 ± 0.6% vs. + 3.6 ± 0.6%, in T2DM vs. HC, respectively, p > 0.05). Multiple regression revealed that HDL-cholesterol, fasted insulin levels and exercise tolerance accounted for 30.5% of the variance in response of myocardial deformation in the T2DM group (p = 0.002). Conclusion Myocardial deformation is reduced in well-controlled T2DM and despite adequate responses, such differences persist during exercise. Trial registration NCT03299790, initially released 09/12/2017.